This document contains a SWOT analysis of Dyno Therapeutics, a company pioneering the use of artificial intelligence in gene therapy. The SWOT analysis identifies Dyno's strengths as access to highly trained scientists and use of AI to advance gene therapy. Weaknesses include being a new company and lack of brand recognition. Opportunities lie in partnerships and investments, while threats include competition and varying drug price regulations. The conclusion notes that SWOT analysis is useful but has limitations, and a deeper analysis is needed to prioritize different factors.

1. NAME:SIMA BISWAS
ROLL NO:2005101023
SEMESTER: 4TH (2ND YEAR)
DEPARTMENT: BTECH-BIOTECHNOLOGY
COURSE CODE: EDBM-201
SWOTANALYSIS

2. INTRODUCTION
 SWOT (strengths, weaknesses, opportunities, and threats)
analysis is a framework used to evaluate a company's
competitive position and to develop strategic planning.
SWOT analysis assesses internal and external factors, as
well as current and future potential. A SWOT analysis is
designed to facilitate a realistic, fact-based, data-driven
look at the strengths and weaknesses of an organization,
initiatives, or within its industry. The organization needs to
keep the analysis accurate by avoiding pre-conceived beliefs
or gray areas and instead focusing on real-life contexts.
Companies should use it as a guide and not necessarily as a
prescription.

3. ComponentsofSWOTanalysis
 Strengths:
Strengths describe what an organization excels at and
what separates it from the competition. a strong brand,
loyal customer base, a strong balance sheet, unique
technology, and so on. Basically, strengths require a strong
reputation in the market place and expertise in partner
level HRM consultancy.
 Weaknesses:
Weaknesses stop an organization from performing at its
optimum level. They are areas where the business needs to
improve to remain competitive. A weak brand, higher-than-
average turnover, high levels of debt, an inadequate supply
chain, or lack of capital.

4.  Opportunities:
Opportunities refer to favorable external factors that
could give an organization a competitive advantage.
Identified market for consultancy in areas other than
HRM.
 Threats:
Threats refer to factors that have the potential to harm
an organization. Common threats include things like
rising costs for materials, increasing competition, tight
labor supply and so on. Large consultancies operating
at a minor level. Other small consultancies looking to
invade the marketplace

5. SWOTTable

6. About:
 Analysts present a SWOT analysis as a square segmented
into four quadrants, each dedicated to an element of
SWOT. This visual arrangement provides a quick
overview of the company’s position. Although all the
points under a particular heading may not be of equal
importance, they all should represent key insights into
the balance of opportunities and threats, advantages and
disadvantages, and so forth.
 The SWOT table is often laid out with the internal factors
on the top row and the external factors on the bottom
row. In addition, the items on the left side of the table are
more positive/favorable aspects, while the items on the
right are more concerning/negative elements.

7. WhyisSWOTanalysisused
 A SWOT analysis is used to strategically identify
areas of improvement or competitive advantages
for a company. In addition to analyzing thing that
a company does well, SWOT analysis takes a look
at more detrimental, negative elements of a
business. Using this information, a company can
make smarter decisions to preserve what it does
well, capitalize on its strengths, mitigate risk
regarding weaknesses, and plan for events that
may adversely affect the company in the future.

8. SWOTanalysisonDynotherapeutics
Dyno Therapeutics is pioneering an artificial
intelligence (AI) powered approach to gene
therapy. Using machine learning and quantitative
high-throughput in vivo experimentation, they are
inventing new ways to design gene vectors with a
focus on cell-targeting capsid proteins from adeno-
associated virus (AAV), the most widely-used vector
for gene therapies.

9. 1. Strengths:
 Access to pool of highly trained scientists.
 Good research and development efforts.
 Amount of Knowledge
 Use of Artificial Intelligence(A.I.) in gene therapy.
 Use of technology to open new gates in Bio-pharma
industry.
2. Weaknesses:
 Key man-power may not be there.
 They are a new company and have not reached a larger
scale.
 They have not developed a good brand image in the
market.
 High development cost.
 Risk aversion among pharma leaders.

10. 3. Opportunities:
 Partnership with bio-tech firms and experts in market
access and data generation.
 Open source health economic models.
 Strategic partnership with payers.
 Significant investments from MNCs.
 Offering a new standards of care.
4. Threats:
 Use of the same or better technology by competitors.
 Varying price regulations on medicines across US and
European markets.
 Small patient population for rare diseases.
 Diversity in HTA(Health Technology Assessment )
Framework.
 R&D restricted by lack of animal testing.

11. Conclusion
Bottom Line:
 A SWOT analysis is a great way to guide business-strategy
meetings. It's powerful to have everyone in the room discuss
the company's core strengths and weaknesses, define the
opportunities and threats, and brainstorm ideas. Oftentimes,
the SWOT analysis you envision before the session changes
throughout to reflect factors you were unaware of and would
never have captured if not for the group’s input.
 Although a useful planning tool, SWOT has limitations. It is
one of several business planning techniques to consider and
should not be used alone. Also, each point listed within the
categories is not prioritized the same. SWOT does not account
for the differences in weight. Therefore, a deeper analysis is
needed, using another planning technique.

12. bibliography
 Investopedia.com
 Wikipedia.com
 dynotx.com